We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2615:TWSEWan Hai Lines Ltd. Analysis

Data as of 2026-03-15 - not real-time

₩10,130.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

EGIS is trading in a clear bearish technical environment. The price sits just below its 20‑day and 50‑day simple moving averages, while the MACD histogram remains in negative territory, indicating downward momentum. RSI hovers in the mid‑40s, suggesting limited upside pressure and no oversold condition. Volume has been contracting, with today’s trade activity well under its recent 10‑day and 3‑month averages, reinforcing the lack of buying interest. Volatility is extreme, with a 30‑day swing exceeding 120%, and the stock’s beta is nearly double the market, amplifying price swings. The broader market sentiment is in a "Greed" phase, yet the stock’s max drawdown of over 60% underscores significant downside risk. With no earnings, cash flow or dividend data available, valuation metrics are essentially blind, making any price assessment speculative. The support level sits well below current levels, while resistance remains far higher, framing a wide trading range. Given these dynamics, the short‑term outlook is cautious, the medium‑term view hinges on a potential bottom‑finding near support, and the long‑term narrative depends on the company’s ability to generate earnings in its niche mapping software market.
Overall, investors should treat EGIS as a high‑risk, technically weak position that lacks fundamental clarity, and any exposure should be sized conservatively.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • Decreasing volume indicating waning demand
  • High volatility and beta amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Proximity to a defined support level offering potential bounce
  • Continued technical weakness but no clear breakout
  • Absence of earnings or cash flow data limiting valuation confidence

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental opacity – no revenue or profitability metrics disclosed
  • Sector exposure to technology and software, which can be growth‑oriented over time
  • Elevated systematic risk (beta) and extreme price volatility

Key Metrics & Analysis

Financial Health

Industry P/E33.7

Technical Analysis

TrendBearish
RSI46.7
Support₩7,910.00
Resistance₩13,920.00
MA 20₩10,652.00
MA 50₩10,682.80
MA 200₩11,585.67
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

GradeFair
TypeValue

Risk Assessment

Beta1.91
Volatility122.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.